Utilizamos cookies propias y de terceros para identificar la sesión del usuario y mejorar nuestros servicios mediante el análisis de sus hábitos de navegación. Si continúa navegando por el sitio web manifiesta consentir su instalación y uso conforme lo anterior. Puede cambiar la configuración y obtener más información aquí.

Bibliografía científicaBibliografía científica

En esta sección encontrará una selección de las publicaciones científicas sobre los Trastornos del Movimiento para los 11 diferentes tipos establecidos por la International Parkinson & Movement Disorder Society. Se han seleccionado sólo aquellas publicaciones que presenten el término de búsqueda en el título (inglés).

Los artículos presentados incluyen aquellos publicados desde enero de 2010. El listado de publicaciones de actualizará mensualmente. Si lo desea, puede recibir una alerta de la actualización por correo electrónico. Para ello ha de registrarse.

Resúmenes publicados
Búsqueda
Trastornos del movimiento Movement disorders 114 artículos Viendo del 1 al 40 de 114 artículos
Pub MED

Eye Movement Disorders and the Cerebellum.NUEVO

Shemesh AA, Zee DS.
J Clin Neurophysiol. 2019 Nov;36(6):405-414. doi: 10.1097/WNP.0000000000000579.
Pub MED

Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists.NUEVO

Alcalay RN, Kehoe C, Shorr E, Battista R, Hall A, Simuni T, Marder K, Wills AM, Naito A, Beck JC, Schwarzschild MA, Nance M.
Genet Med. 2019 Nov 4. doi: 10.1038/s41436-019-0684-x. [Epub ahead of print] Erratum in: Genet Med. 2019 Nov 27;:.
Pub MED

Movement Disorders in Prionopathies: A Systematic Review.NUEVO

Rodriguez-Porcel F, Ciarlariello VB, Dwivedi AK, Lovera L, Da Prat G, Lopez-Castellanos R, Suri R, Laub H, Walker RH, Barsottini O, Pedroso JL, Espay AJ.
Tremor Other Hyperkinet Mov (N Y). 2019 Dec 12;9. doi: 10.7916/tohm.v0.712. eCollection 2019. Review.
Pub MED

Reduced drift rate: a biomarker of impaired information processing in functional movement disorders.NUEVO

Sadnicka A, Daum C, Meppelink AM, Manohar S, Edwards M.
Brain. 2019 Dec 22. pii: awz387. doi: 10.1093/brain/awz387. [Epub ahead of print]
Pub MED

Movement disorders in the elderly.NUEVO

Doridam J, Mongin M, Degos B.
Geriatr Psychol Neuropsychiatr Vieil. 2019 Dec 1;17(4):395-404. doi: 10.1684/pnv.2019.0825.
Pub MED

Movement Disorders Journal: Yesterday, Today, Tomorrow, and Always.NUEVO

Obeso JA, Stoessl AJ, Nash JL, Olanow CW.
Mov Disord. 2019 Dec;34(12):1814-1816. doi: 10.1002/mds.27944. No abstract available.
Pub MED

Movement disorders: a themed collection.NUEVO

Haunton VJ.
Age Ageing. 2019 Dec 1;49(1):12-15. doi: 10.1093/ageing/afz147.
Pub MED

The expanding spectrum of movement disorders in genetic epilepsies.NUEVO

Papandreou A, Danti FR, Spaull R, Leuzzi V, Mctague A, Kurian MA.
Dev Med Child Neurol. 2019 Nov 29. doi: 10.1111/dmcn.14407. [Epub ahead of print] Review.
Pub MED

Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion.NUEVO

Dosekova P, Dubiel A, Karlowicz A, Zietkiewicz S, Rydzanicz M, Habalova V, Pienkowski VM, Skirkova M, Han V, Mosejova A, Gdovinova Z, Kaliszewska M, Tońska K, Szymanski MR, Skorvanek M, Ploski R.
Eur J Med Genet. 2019 Nov 26:103821. doi: 10.1016/j.ejmg.2019.103821. [Epub ahead of print]
Pub MED

Diagnostic Value of Acoustic and Aerodynamic Measurements in Vocal Fold Movement Disorders and their Correlation with Laryngeal Electromyography and Voice Handicap Index.NUEVO

Valentino WL, Park J, Alnouri G, Gracely EJ, Tami A, Vance D, Palmer J, Sataloff RT.
J Voice. 2019 Nov 19. pii: S0892-1997(19)30397-2. doi: 10.1016/j.jvoice.2019.10.008. [Epub ahead of print]
Pub MED

Reply to: The Spectrum of Movement Disorders in 18p Deletion Syndrome.NUEVO

Crosiers D, Blaumeiser B, Van Goethem G.
Mov Disord Clin Pract. 2019 Oct 23;6(8):731-732. doi: 10.1002/mdc3.12835. eCollection 2019 Nov. No abstract available.
Pub MED

The Spectrum of Movement Disorders in 18-p Deletion Syndrome.NUEVO

Vela-Desojo L, Rojo-Sebastian A, Baron-Rubio M, Badenes D.
Mov Disord Clin Pract. 2019 Oct 23;6(8):729-730. doi: 10.1002/mdc3.12834. eCollection 2019 Nov. No abstract available.
Pub MED

Implementation of an integrated multidisciplinary Movement Disorders Clinic: applying a knowledge translation framework to improve multidisciplinary care.NUEVO

Shrubsole K.
Disabil Rehabil. 2019 Nov 19:1-13. doi: 10.1080/09638288.2019.1691666. [Epub ahead of print]
Pub MED

Diagnostic Yield of a Targeted Next-Generation Sequencing Gene Panel for Pediatric-Onset Movement Disorders: A 3-Year Cohort Study.NUEVO

Graziola F, Garone G, Stregapede F, Bosco L, Vigevano F, Curatolo P, Bertini E, Travaglini L, Capuano A.
Front Genet. 2019 Oct 29;10:1026. doi: 10.3389/fgene.2019.01026. eCollection 2019.
Pub MED

Movement disorders rounds: A case of missing pathology in a patient with LRRK2 Parkinson's disease.NUEVO

Agin-Liebes J, Cortes E, Vonsattel JP, Marder K, Alcalay RN.
Parkinsonism Relat Disord. 2019 Nov 9. pii: S1353-8020(19)30478-X. doi: 10.1016/j.parkreldis.2019.11.006. [Epub ahead of print] No abstract available.
Pub MED

Music Therapy and Music-Based Interventions for Movement Disorders.NUEVO

Devlin K, Alshaikh JT, Pantelyat A.
Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):83. doi: 10.1007/s11910-019-1005-0. Review.
Pub MED

Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.NUEVO

Dilks S, Xavier RM, Kelly C, Johnson J.
Nurs Clin North Am. 2019 Dec;54(4):595-608. doi: 10.1016/j.cnur.2019.08.004. Epub 2019 Oct 10. Review.
Pub MED

Abstracts of the 2019 International Congress of the Parkinson's Disease and Movement Disorders®.

[No authors listed]
Mov Disord. 2019 Oct;34 Suppl 2:S1-S930. doi: 10.1002/mds.27795. No abstract available.
Pub MED

Localising movement disorders in childhood.

Bamford NS, McVicar K.
Lancet Child Adolesc Health. 2019 Oct 22. pii: S2352-4642(19)30330-X. doi: 10.1016/S2352-4642(19)30330-X. [Epub ahead of print] Review.
Pub MED

Functional movement disorders.

Galli S, Béreau M, Magnin E, Moulin T, Aybek S.
Rev Neurol (Paris). 2019 Oct 9. pii: S0035-3787(19)30541-7. doi: 10.1016/j.neurol.2019.08.007. [Epub ahead of print] Review.
Pub MED

A Power Spectral Density-Based Method to Detect Tremor and Tremor Intermittency in Movement Disorders.

Luft F, Sharifi S, Mugge W, Schouten AC, Bour LJ, van Rootselaar AF, Veltink PH, Heida T.
Sensors (Basel). 2019 Oct 4;19(19). pii: E4301. doi: 10.3390/s19194301.
Pub MED

Impaired Action Control in Patients With Functional Movement Disorders.

van Wouwe NC, Mohanty D, Lingaiah A, Wylie SA, LaFaver K.
J Neuropsychiatry Clin Neurosci. 2019 Oct 7:appineuropsych19030076. doi: 10.1176/appi.neuropsych.19030076. [Epub ahead of print]
Pub MED

Functionally meaningful rating scales in progressive pediatric movement disorders.

Perlman S.
Dev Med Child Neurol. 2019 Oct 3. doi: 10.1111/dmcn.14372. [Epub ahead of print] No abstract available.
Pub MED

Deep Brain Stimulation in Movement Disorders: From Experimental Surgery to Evidence-Based Therapy.

Krack P, Volkmann J, Tinkhauser G, Deuschl G.
Mov Disord. 2019 Oct 3. doi: 10.1002/mds.27860. [Epub ahead of print]
Pub MED

Internal Versus External Frame of Reference in Functional Movement Disorders.

Vizcarra JA, Hacker S, Lopez-Castellanos R, Ryes L, Laub HN, Marsili L, Dwivedi AK, LaFaver K, Espay AJ.
J Neuropsychiatry Clin Neurosci. 2019 Sep 30:appineuropsych18110290. doi: 10.1176/appi.neuropsych.18110290. [Epub ahead of print]
Pub MED

Determinants of ferritin response to oral iron supplementation in children with sleep movement disorders.

DelRosso LM, Yi T, Chan JHM, Wrede JE, Lockhart CT, Ferri R.
Sleep. 2019 Sep 29. pii: zsz234. doi: 10.1093/sleep/zsz234. [Epub ahead of print]
Pub MED

Paroxysmal movement disorders - practical update on diagnosis and management.

De Gusmao CM, Silveira-Moriyama L.
Expert Rev Neurother. 2019 Sep;19(9):807-822. doi: 10.1080/14737175.2019.1648211. Epub 2019 Aug 8.
Pub MED

Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders.

Antonazzo M, Botta M, Bengoetxea H, Ruiz-Ortega JÁ, Morera-Herreras T.
Int Rev Neurobiol. 2019;146:229-257. doi: 10.1016/bs.irn.2019.06.012. Epub 2019 Jun 28.
Pub MED

Gabapentin for pain, movement disorders, and irritability in neonates and infants.

Burnsed JC, Heinan K, Letzkus L, Zanelli S.
Dev Med Child Neurol. 2019 Jul 25. doi: 10.1111/dmcn.14324. [Epub ahead of print]
Pub MED

The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.

Latorre A, Rocchi L, Berardelli A, Bhatia KP, Rothwell JC.
Mov Disord. 2019 Jul;34(7):936-949. doi: 10.1002/mds.27736. Epub 2019 Jun 10. Review.
Pub MED

Cognition and Evolution of Movement Disorders of FOXG1-Related Syndrome.

Wong LC, Wu YT, Hsu CJ, Weng WC, Tsai WC, Lee WT.
Front Neurol. 2019 Jun 28;10:641. doi: 10.3389/fneur.2019.00641. eCollection 2019.
Pub MED

Patient Experience with Rechargeable Implantable Pulse Generator Deep Brain Stimulation for Movement Disorders.

Mitchell KT, Volz M, Lee A, San Luciano M, Wang S, Starr PA, Larson P, Galifianakis NB, Ostrem JL.
Stereotact Funct Neurosurg. 2019;97(2):113-119. doi: 10.1159/000500993. Epub 2019 Jul 9.
Pub MED

Antisense therapies for movement disorders.

Scoles DR, Pulst SM.
Mov Disord. 2019 Aug;34(8):1112-1119. doi: 10.1002/mds.27782. Epub 2019 Jul 8. Review.
Pub MED

Recent developments in drug-induced movement disorders: a mixed picture.

Factor SA, Burkhard PR, Caroff S, Friedman JH, Marras C, Tinazzi M, Comella CL.
Lancet Neurol. 2019 Sep;18(9):880-890. doi: 10.1016/S1474-4422(19)30152-8. Epub 2019 Jul 3. Review.
Pub MED

Reliability in Mandibular Movement Evaluation Using Photogrammetry in Patients With Temporomandibular Disorders.

Andrade RM, Guimarães LR, Ribeiro AP, Pasqual Marques A, Crivello O Jr, Gonçalves de Carvalho BK, Amado João SM.
J Manipulative Physiol Ther. 2019 May;42(4):267-275. doi: 10.1016/j.jmpt.2018.11.008. Epub 2019 Jun 29.
Pub MED

Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.

Peralta C, Biafore F, Depetris TS, Bastianello M.
Curr Neurol Neurosci Rep. 2019 Jun 29;19(8):56. doi: 10.1007/s11910-019-0966-3. Review.
Pub MED

Editorial: Update on movement disorders.

Svenningsson P, Frucht SJ.
Curr Opin Neurol. 2019 Aug;32(4):564-565. doi: 10.1097/WCO.0000000000000709. No abstract available.
Pub MED

A dyadic group-movement therapy with adolescent girls with eating disorders.

Dor-Haim M, Yaroslavsy A, Lev Azolay T, Dascal T, Toledano A, Latzer Y, Stein D.
J Clin Psychol. 2019 Aug;75(8):1429-1443. doi: 10.1002/jclp.22785. Epub 2019 Jun 26.
Pub MED

Gene-targeting approaches for movement disorders: recent advances.

Kaplitt MG.
Curr Opin Neurol. 2019 Aug;32(4):566-570. doi: 10.1097/WCO.0000000000000719.
Pub MED

Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy.

Musco S, Ruekert L, Myers J, Anderson D, Welling M, Cunningham EA.
J Clin Psychopharmacol. 2019 Jul/Aug;39(4):336-343. doi: 10.1097/JCP.0000000000001061.
Viendo del 1 al 40 de 114 artículos
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:

Sociedad Española de Neurología

Sociedad Española
de Neurología
En colaboración con:

Zambon

Haga click en el logo para acceder
a información acerca de Zambon
NeuroAcademy